The store will not work correctly when cookies are disabled.
1-(azepan-1-yl)-3-(9H-carbazol-9-yl)propan-2-ol
ID: ALA4518197
Cas Number: 91324-15-1
PubChem CID: 56211
Max Phase: Preclinical
Molecular Formula: C21H26N2O
Molecular Weight: 322.45
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: OC(CN1CCCCCC1)Cn1c2ccccc2c2ccccc21
Standard InChI: InChI=1S/C21H26N2O/c24-17(15-22-13-7-1-2-8-14-22)16-23-20-11-5-3-9-18(20)19-10-4-6-12-21(19)23/h3-6,9-12,17,24H,1-2,7-8,13-16H2
Standard InChI Key: XZMXXDXFHOVSEF-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
4.0730 -12.2603 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3684 -11.8411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4255 -11.0267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1566 -10.6655 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1612 -9.8575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7742 -9.3230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5821 -9.5064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9432 -10.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5981 -10.9924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7962 -11.1547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6550 -12.2390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6462 -13.0561 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9771 -13.5265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2197 -14.3089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6634 -14.9080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8686 -14.7288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6261 -13.9464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1783 -13.3473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0367 -14.3177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2994 -13.5458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1012 -13.3877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6404 -14.0014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3778 -14.7773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5760 -14.9355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
4 10 1 0
2 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
13 18 1 0
14 19 1 0
19 20 2 0
12 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
19 24 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 322.45 | Molecular Weight (Monoisotopic): 322.2045 | AlogP: 4.03 | #Rotatable Bonds: 4 |
Polar Surface Area: 28.40 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.12 | CX LogP: 4.00 | CX LogD: 1.34 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.79 | Np Likeness Score: -0.75 |
References
1. Wang T, Mäser P, Picard D.. (2016) Inhibition of Plasmodium falciparum Hsp90 Contributes to the Antimalarial Activities of Aminoalcohol-carbazoles., 59 (13): [PMID:27312008] [10.1021/acs.jmedchem.6b00591] |
2. Clausen JD, Kjellerup L, Cohrt KO, Hansen JB, Dalby-Brown W, Winther AL.. (2017) Elucidation of antimicrobial activity and mechanism of action by N-substituted carbazole derivatives., 27 (19): [PMID:28893470] [10.1016/j.bmcl.2017.08.067] |